No one wants to be diagnosed with or go through the physical and psychological toll of cancer. Which is why, sometimes, it's ...

Alembic Pharmaceuticals has secured final USFDA approval for its generic version of Doxorubicin Hydrochloride Liposome, a ...

The man and the woman standing side by side are like family, though they met by chance. She saved his life. Now, Marc Franke ...

Stopping unnecessary cancer screenings can take over a decade after new guidelines are introduced, according to a review ...

Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...

Higher rates of cancers associated with immunosuppression in ethnically minoritized men living with HIV highlight gaps in HIV diagnosis and treatment.

Cancer in Uganda is arguably one of the scariest diseases to think about, later alone suffer from or deal with a patient ...

It's incredibly scary to experience a random symptom out of nowhere, especially when it won't go away. So when I saw Reddit ...

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...

Karen Knudsen is leading Sean Parker’s cancer immunotherapy incubator where philanthropy and venture capital meet.

HSHS St. John's Hospital is pioneering a new procedure using blue light technology to enhance the detection of bladder cancer ...

According to IQVIA, the market for Doxorubicin Hydrochloride Liposome Injection is estimated at $29 million for the twelve ...